All Chikungunya virus articles
-
NewsInvasive mosquito species detected in east London
The UK Health Security Agency (UKHSA) is undertaking enhanced surveillance and trapping activities following the detection of invasive Aedes aegypti mosquitoes and larvae at nearby residential properties in east London.
-
NewsIdentification and characterization of anti-chikungunya virus compounds using a biosafe toolkit
A new study characterizes several novel anti-chikungunya virus compounds and highlights the potential of combining screening approaches with mechanistic analyses to explore new antiviral strategies against emerging viral pathogens.
-
NewsWorld Mosquito Day 2026: the essential role of mosquito control in tackling increases in mosquito-borne diseases in Europe
EU scientists urge that continued research into interventions and cross-sectoral collaboration is needed to develop effective mosquito control strategies, to help address the increase in mosquito-borne diseases in Europe.
-
NewsNew vaccine strategy protects against chikungunya and could become a platform for combating other diseases
Researchers created a genetically modified version of the Chikungunya virus that replicates only once, yet still trains the immune system to defend itself without causing disease.
-
NewsMultisite test strip boosts mosquito-borne virus detection
A research team has developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that enables highly sensitive, portable detection of mosquito-borne viruses, using Chikungunya virus (CHIKV) as a model target.
-
NewsChikungunya fever: Etiology, pathogenesis, and management, with evidence-based application of traditional Chinese medicine
Traditional Chinese medicine (TCM) offers complementary strategies for acute symptoms and chronic polyarthralgia in Chikungunya infection. A review synthesizes current knowledge on etiology, pathogenesis, clinical features, and management.
-
NewsResearchers may now understand why chikungunya virus infections turn chronic
About half of people infected with chikungunya virus will progress to a chronic form of the disease. A new study finds that chikungunya virus persists in joint-associated macrophages, a specialized type of white blood cell that helps the body defend against pathogens.
-
NewsNorth America and Europe could become hotspots for chikungunya virus due to climate change
Enabled by global heating, mosquito-borne chikungunya virus is likely to spread into temperate regions. Under climate change models, the virus will further expand northward into temperate regions, especially northeastern North America, central Europe, and East Asia, researchers say.
-
NewsResearchers discover new mosquito-specific viruses
A new study looked at mosquitoes’ immune response to discover many more insect viruses. Researchers hope to someday use the mosquitoes’ own immune system to battle some of the most pervasive and antagonistic human viruses.
-
NewsDebilitating virus can spread in cool weather, increasing health risk in Europe
Chikungunya virus, a debilitating tropical disease caused by infected mosquito bites, poses a greater health threat in Europe than previously thought because it can be spread when air temperatures are as low as 13 degrees Celsius.
-
NewsValneva provides update on recommendations for use of IXCHIQ® in UK
Valneva SE has announced that following a review of the benefits and risks of the Company’s single-dose chikungunya vaccine, IXCHIQ® , the United Kingdom’s (UK) Commission on Human Medicines (CHM) has updated its recommendations for use of the vaccine.
-
NewsResearchers on the cusp of a vaccine for a global health threat
Researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue. The team tested whether they could engineer E. coli to assemble biopolymer particles which displayed chikungunya antigens and performed as a vaccine.
-
NewsIn rare cases, autoantibodies can cause severe reactions to a live-attenuated virus Chikungunya vaccine that has been discontinued in the U.S.
A new study shows that preexisting autoantibodies in a small subset of the population can allow weakened vaccine viruses to escape control, explaining some adverse events tied to one kind of Chikungunya vaccine, which is no longer available in the U.S.
-
CareersThe National Collection of Pathogenic Viruses (NCPV): a critical resource for virology and public health
It’s now 25 years since the National Collection of Pathogenic Viruses (NCPV) was founded as a dedicated, secure, and relevant national virus repository for the UK. Jane Burton, Teresa Ramalho and Tilly Maybery explore how the collection has evolved - and is tackling future global health concerns.
-
NewsValneva provides update on Chikungunya vaccine IXCHIQ®
Valneva SE has announced that the company has decided to voluntarily withdraw the biologics license application (BLA) and Investigational New Drug (IND) application for its chikungunya vaccine, IXCHIQ® , in the United States, following suspension of the license by the FDA.
-
NewsMosquito saliva may hold clues to fighting chikungunya inflammation
Scientists have uncovered a surprising mechanism showing how mosquito saliva can alter the human body’s immune response during chikungunya virus (CHIKV) infection - it not only transmits the virus but also influences how the body’s immune system responds.
-
NewsResearchers deconstruct chikungunya outbreaks to improve prediction and vaccine development
Researchers analyzed more than 80 outbreaks of chikungunya virus to improve prediction of future outbreaks and inform vaccine trial development.
-
NewsIndia could bear biggest impact from chikungunya, new maps suggest
Based on existing evidence of chikungunya transmission, an infectious disease model predicts 14.4 million people could be at risk of infections globally each year, with 5.1 million people at risk in India.
-
NewsHeadspace invaders: How mosquito-borne viruses breach the brain’s defenses
Using a stem cell-based model of the human blood-brain barrier, researchers compared two closely related Sindbis virus strains — one brain-invading and one not — and found that small changes in viral surface proteins called glycoproteins dictate whether the virus can cross.
-
NewsPediatric investigation study re-examines chikungunya in neglected pediatric victims
Researchers and policymakers must recalibrate their outlook on pediatric chikungunya to develop effective control measures, a new paper warns.